🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1134
-0.0273 (-19.40%)
At close: Nov 17, 2026, 4:00 PM EST
0.1146
+0.0012 (1.06%)
Pre-market: Nov 18, 2026, 6:59 AM EST

AEON Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-39.2242.01-384.63-52.56-55.64
Depreciation & Amortization
0.080.10.10.070
Other Amortization
---0.331.98
Asset Writedown & Restructuring Costs
--348--
Stock-Based Compensation
5.326.2575.895.22
Other Operating Activities
23.46-69.35-15.554.4118.59
Change in Accounts Payable
-4.972.52-4.596.61-0.9
Change in Other Net Operating Assets
-1.97-1.821.85-0.352.31
Operating Cash Flow
-17.31-20.29-47.83-35.58-28.43
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0---0.31-0.17
Investing Cash Flow
-0---0.31-0.17

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-151444.515
Long-Term Debt Repaid
----3.99-
Total Debt Repaid
----3.99-
Net Debt Issued (Repaid)
-151440.5115
Issuance of Common Stock
18.510.15---
Other Financing Activities
1.79----1.44
Financing Cash Flow
20.3115.151440.5113.56

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
2.99-5.15-33.834.62-15.04

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-17.31-20.29-47.83-35.89-28.6
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.75-35.23-0.62-18.61-16.31
Levered Free Cash Flow
-11-10.3-25.48-16.79-14.85
Unlevered Free Cash Flow
-11-10.3-25.48-16.79-14.85

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-6.940.71-2.746.271.42
SEC Filings: 10-K · 10-Q